Diploma PLC
LSE:DPLM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 228
4 632
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Diploma PLC
Diploma PLC
Total Liabilities & Equity
Diploma PLC
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Diploma PLC
LSE:DPLM
|
Total Liabilities & Equity
£1.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
30%
|
CAGR 10-Years
21%
|
|
|
F
|
Ferguson PLC
NYSE:FERG
|
Total Liabilities & Equity
$16.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Howden Joinery Group PLC
LSE:HWDN
|
Total Liabilities & Equity
£2.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
|
Bunzl plc
LSE:BNZL
|
Total Liabilities & Equity
£9.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
|
Ashtead Group PLC
LSE:AHT
|
Total Liabilities & Equity
$22.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
|
|
RS Group PLC
LSE:RS1
|
Total Liabilities & Equity
£2.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Diploma PLC
Glance View
Diploma PLC, a British company with a rich history, is known for its unique approach to adding value in otherwise niche markets since its inception in 1931. The company thrives on its strategy of acquiring and nurturing small-to-medium enterprises and integrating them into its core business areas—Life Sciences, Seals, and Controls. Each of these sectors functions with a tailored approach, yet all are intricately tied under the umbrella of specialisation and high-performance capabilities. In the Life Sciences business, Diploma supplies essential consumables and services to the healthcare and environmental industries, focusing on sectors where precision and dependability are paramount. Through its Seals business, it offers vital components and solutions to industries ranging from heavy mobile machinery to aerospace, while the Controls segment provides a broad array of wiring, cable, and related products. What sets Diploma PLC apart is its diversified revenue model coupled with a decentralized operating philosophy, allowing its businesses to maintain the agility of smaller entities while benefiting from the strength of a larger organization. Diploma’s well-practiced strategy of acquiring entrepreneurial companies, often family-owned, allows them to expand while retaining their unique DNA. The company then enhances these businesses by infusing operational efficiencies, leveraging its global reach, and encouraging best practice sharing across its decentralized network. This model not only stimulates organic growth but also ensures steady cash flow, resilience to market fluctuations, and sustainable profitability. In essence, Diploma PLC has carved out its niche by fostering growth through strategic acquisitions and operational excellence, ensuring its enduring success in specialised markets.
See Also
What is Diploma PLC's Total Liabilities & Equity?
Total Liabilities & Equity
1.5B
GBP
Based on the financial report for Mar 31, 2024, Diploma PLC's Total Liabilities & Equity amounts to 1.5B GBP.
What is Diploma PLC's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
21%
Over the last year, the Total Liabilities & Equity growth was 10%. The average annual Total Liabilities & Equity growth rates for Diploma PLC have been 19% over the past three years , 30% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
